I 

118TH CONGRESS 

2D SESSION H. R. 8247 

To authorize the Secretary of Health and Human Services to award grants 

to increase early detection of and intervention for uterine fibroids, and 

for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

MAY 6, 2024 

Ms. BROWN (for herself, Ms. CLARKE of New York, Mrs. CHERFILUS-MCCORMICK, Ms. LOIS FRANKEL of Florida, Mrs. BEATTY, Mr. JACKSON of Illinois, Ms. NORTON, Ms. JACKSON LEE, Ms. KAMLAGER-DOVE, Ms. 

KELLY of Illinois, Mrs. HAYES, Mrs. TRAHAN, Mr. LIEU, Mr. FROST, 

Ms. STEVENS, Mrs. WATSON COLEMAN, Mrs. RAMIREZ, Ms. MOORE of 

Wisconsin, Ms. STRICKLAND, Ms. JACOBS, Mr. VEASEY, Ms. WILLIAMS

of Georgia, Mr. GRIJALVA, Ms. JAYAPAL, Ms. PLASKETT, Ms. PRESSLEY, 

Ms. SEWELL, Mr. JOHNSON of Georgia, Mr. CASAR, Mrs. FOUSHEE, Ms. 

BLUNT ROCHESTER, Mr. CARSON, and Ms. BUDZINSKI) introduced the 

following bill; which was referred to the Committee on Energy and Commerce 

A BILL 

To authorize the Secretary of Health and Human Services 

to award grants to increase early detection of and intervention for uterine fibroids, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
2 

•HR 8247 IH

1 SECTION 1. SHORT TITLE. 

2 This Act may be cited as the ‘‘Uterine Fibroid Inter3 vention and Gynecological Health Treatment Act of 

4 2024’’. 

5 SEC. 2. RESEARCH ON UTERINE FIBROID EARLY DETEC6 TION AND INTERVENTION. 

7 (a) IN GENERAL.—The Secretary of Health and 

8 Human Services (in this Act referred to as the ‘‘Sec9 retary’’) shall— 

10 (1) conduct or support research on increasing 

11 early detection of, and intervention for, uterine 

12 fibroids; and 

13 (2) based on the results of such research and 

14 other relevant information, formulate evidence-based 

15 or evidence-informed strategies to increase early de16 tection in health care settings. 

17 (b) TIMELINE.—The Secretary shall finalize the evi18 dence-based or evidence-informed strategies required by 

19 subsection (a)(2) as expeditiously as possible in order to 

20 make such strategies available to grantees under section 

21 3 to implement such strategies pursuant to section 

22 3(b)(3). 

23 SEC. 3. GRANTS WITH RESPECT TO UTERINE FIBROID 

24 EARLY DETECTION AND INTERVENTION. 

25 (a) IN GENERAL.—The Secretary of Health and 

26 Human Services (in this Act referred to as the ‘‘SecVerDate Sep 11 2014 03:41 Jun 01, 2024 Jkt 049200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\H8247.IH H8247

kjohnson on DSK7ZCZBW3PROD with $$_JOB
3 

•HR 8247 IH

1 retary’’) may award grants to States for carrying out pro2 grams— 

3 (1) to increase early detection of and interven4 tion for uterine fibroids; and 

5 (2) to develop and implement public awareness 

6 and education campaigns for the early detection and 

7 intervention of uterine fibroids. 

8 (b) USE OF FUNDS.—A State receiving a grant under 

9 this section may use the grant, with respect to increasing 

10 early detection of and intervention for uterine fibroids, for 

11 the following activities: 

12 (1) Screening procedures, including advanced 

13 gynecological imaging (including payment therefor). 

14 (2) Patient navigation services. 

15 (3) Implementation of evidence-based or evi16 dence-informed strategies proven to increase early 

17 detection in health care settings. 

18 (4) Facilitating access to health care settings. 

19 (c) PRIORITY.—In awarding grants under this sec20 tion, the Secretary shall give priority to States proposing 

21 to carry out a program in a geographic areas in which 

22 there are socially vulnerable populations with elevated risk 

23 of uterine fibroid development. 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
4 

•HR 8247 IH

1 SEC. 4. RESEARCH WITH RESPECT TO UTERINE FIBROID 

2 EARLY DETECTION AND INTERVENTION. 

3 The Secretary may award grants to conduct research, 

4 which may include clinical trials, related to— 

5 (1) disparities in pain control and management 

6 in uterine fibroid surgical treatment; or 

7 (2) Asherman’s Syndrome, intrauterine adhe8 sions, and other intrauterine conditions as deter9 mined appropriate by the Secretary. 

10 SEC. 5. REPORTS TO CONGRESS. 

11 (a) REPORTS ON GRANTS.—Not later 2 years after 

12 the initial award of grants under this Act, and every 2 

13 years thereafter, the Secretary shall submit to the Con14 gress, and make publicly available on the appropriate 

15 website of the Department of Health and Human Services, 

16 a report summarizing the findings and results of programs 

17 and activities funded through grants under this Act. 

18 (b) REPORT ON RESEARCH DEVELOPMENTS.—Not 

19 later than 2 years after the date of enactment of this Act, 

20 and every 2 years thereafter, the Secretary shall submit 

21 to the Congress, and make publicly available on the appro22 priate website of the Department of Health and Human 

23 Services, a report outlining research developments and 

24 findings related to— 

25 (2) disparities in pain control and management 

26 in uterine fibroid surgical treatment; and 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
5 

•HR 8247 IH

1 (3) Asherman’s Syndrome, intrauterine adhe2 sions, and other intrauterine conditions as deter3 mined appropriate by the Secretary. 

Æ 


kjohnson on DSK7ZCZBW3PROD with $$_JOB